These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37975611)

  • 21. Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis.
    Savica V; Santoro D; Monardo P; Mallamace A; Bellinghieri G
    Ther Clin Risk Manag; 2008 Aug; 4(4):821-6. PubMed ID: 19209264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of phosphate binders on supplemental iron absorption in healthy subjects.
    Pruchnicki MC; Coyle JD; Hoshaw-Woodard S; Bay WH
    J Clin Pharmacol; 2002 Oct; 42(10):1171-6. PubMed ID: 12362933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of phosphate binders in patients with end stage kidney disease undergoing hemodialysis.
    Prajapati VA; Galani VJ; Shah PR
    Saudi J Kidney Dis Transpl; 2014 May; 25(3):530-8. PubMed ID: 24821148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial.
    Bleskestad IH; Bergrem H; Hartmann A; Godang K; Gøransson LG
    BMC Nephrol; 2012 Jun; 13():49. PubMed ID: 22742720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Phase 3 Study of Enarodustat in Anemic Patients with CKD not Requiring Dialysis: The SYMPHONY ND Study.
    Akizawa T; Nangaku M; Yamaguchi T; Koretomo R; Maeda K; Miyazawa Y; Hirakata H
    Kidney Int Rep; 2021 Jul; 6(7):1840-1849. PubMed ID: 34307978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of sevelamer hydrochloride and calcium acetate on the oral bioavailability of ciprofloxacin.
    Kays MB; Overholser BR; Mueller BA; Moe SM; Sowinski KM
    Am J Kidney Dis; 2003 Dec; 42(6):1253-9. PubMed ID: 14655198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sevelamer carbonate: a review in hyperphosphataemia in adults with chronic kidney disease.
    Perry CM; Plosker GL
    Drugs; 2014 May; 74(7):771-92. PubMed ID: 24811546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of Enarodustat in Non-Japanese and Japanese Healthy Subjects and in Patients With End-Stage Renal Disease on Hemodialysis.
    Pai SM; Kambhampati SRP; Naruhashi S; Yamada H
    Clin Pharmacol Drug Dev; 2023 Jul; 12(7):683-690. PubMed ID: 37203396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Hemoglobin Response to Treatment With Enarodustat Using Pharmacometric Approach in Japanese Anemic Patients With Chronic Kidney Disease.
    Naruhashi S; Fujii T; Yamada H; Pai SM; Ninomiya N
    J Clin Pharmacol; 2023 Feb; 63(2):180-196. PubMed ID: 36057843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A highly sensitive and selective UPLC-MS/MS assay for the determination of enarodustat (JTZ-951) in human plasma.
    Pai S; Huang MQ; Maki K; Waldron M; Yoshikawa T; Keller T; Burnett J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1176():122754. PubMed ID: 34052557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-treatment of dairy and breast milk with sevelamer hydrochloride and sevelamer carbonate to reduce phosphate.
    Raaijmakers R; Houkes LM; Schröder CH; Willems JL; Monnens LA
    Perit Dial Int; 2013; 33(5):565-72. PubMed ID: 23636435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The oral hypoxia-inducible factor prolyl hydroxylase inhibitor enarodustat counteracts alterations in renal energy metabolism in the early stages of diabetic kidney disease.
    Hasegawa S; Tanaka T; Saito T; Fukui K; Wakashima T; Susaki EA; Ueda HR; Nangaku M
    Kidney Int; 2020 May; 97(5):934-950. PubMed ID: 32171449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease.
    Rastogi A
    Ther Adv Cardiovasc Dis; 2013 Dec; 7(6):322-42. PubMed ID: 24327730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients.
    Bleyer AJ; Burke SK; Dillon M; Garrett B; Kant KS; Lynch D; Rahman SN; Schoenfeld P; Teitelbaum I; Zeig S; Slatopolsky E
    Am J Kidney Dis; 1999 Apr; 33(4):694-701. PubMed ID: 10196011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, crossover design study of sevelamer carbonate powder and sevelamer hydrochloride tablets in chronic kidney disease patients on haemodialysis.
    Fan S; Ross C; Mitra S; Kalra P; Heaton J; Hunter J; Plone M; Pritchard N
    Nephrol Dial Transplant; 2009 Dec; 24(12):3794-9. PubMed ID: 19666658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.
    Van Buren PN; Lewis JB; Dwyer JP; Greene T; Middleton J; Sika M; Umanath K; Abraham JD; Arfeen SS; Bowline IG; Chernin G; Fadem SZ; Goral S; Koury M; Sinsakul MV; Weiner DE;
    Am J Kidney Dis; 2015 Sep; 66(3):479-88. PubMed ID: 25958079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Phosphate Binders and a Dietary Iron Supplement on the Pharmacokinetics of a Single Dose of Vadadustat in Healthy Adults.
    Paulson SK; Martinez J; Sawant R; Burke SK; Chavan A
    Clin Pharmacol Drug Dev; 2022 Apr; 11(4):475-485. PubMed ID: 35172045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sevelamer carbonate.
    Barna MM; Kapoian T; O'Mara NB
    Ann Pharmacother; 2010 Jan; 44(1):127-34. PubMed ID: 19955298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of dietary phosphate absorption after single doses of lanthanum carbonate and sevelamer carbonate in healthy volunteers: a balance study.
    Martin P; Wang P; Robinson A; Poole L; Dragone J; Smyth M; Pratt R
    Am J Kidney Dis; 2011 May; 57(5):700-6. PubMed ID: 21354682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sevelamer carbonate experience in Indian end stage renal disease patients.
    Abraham G; Kher V; Saxena S; Jayakumar M; Chafekar D; Pargaonkar P; Shetty M; Reddy YN; Reddy YN
    Indian J Nephrol; 2012 May; 22(3):189-92. PubMed ID: 23087553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.